1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow FCN-437c: new trials by email Literature Review of FCN-437c trials Research Report on FCN-437c
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. FCN-437c, Letrozole or anastrozole, Goserelin acetate, Placebo, Letrozole or anastrozole, Goserelin acetate - Advanced Breast Cancer, Female Breast Cancer | Phase 3 | Unknown | Ahon Pharmaceutical Co., Ltd. | 434 | 2022-03-02 | 2022-07-06 |
Ahon Pharmaceutical Co., Ltd. (1)
China (1)
Binghe Xu (1)